Figure 6 | British Journal of Cancer

Figure 6

From: The cyclin-dependent kinase inhibitor p57Kip2 is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer

Figure 6

Scatterplot of mRNA p57kip2 expression levels plotted against length of survival showing association with differences in response to treatment as indicated by symbols. A significant difference between responses (CR versus PR and NR combined) for p57kip2 level, P=0.034 using a one-way ANOVA.

Back to article page